Article
Nutrition & Dietetics
Hao Chen, Xuebing Leng, Shaohui Liu, Ziqi Zeng, Feng Huang, Rongjie Huang, Yunfeng Zou, Yunan Xu
Summary: This study found that dietary intake of omega-3 polyunsaturated fatty acids (N3-PUFA), particularly alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosapentaenoic acid (DPA), was associated with lower risk of all-cause and cardiovascular mortality among hypertensive adults in the U.S.
CLINICAL NUTRITION
(2023)
Review
Environmental Sciences
Priyanshi Sikka, Tapan Behl, Sanchay Sharma, Aayush Sehgal, Saurabh Bhatia, Ahmed Al-Harrasi, Sukhbir Singh, Neelam Sharma, Lotfi Aleya
Summary: Ω-3 fatty acids are recognized for their benefits on physical and mental health, primarily obtained from fish and fish products. Adequate intake of Ω-3 fatty acids can improve brain function and neuronal function, reduce depressive symptoms, and have fewer side effects compared to antidepressants.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
(2021)
Article
Cardiac & Cardiovascular Systems
Richard L. Weinberg, Robert D. Brook, Melvyn Rubenfire, Kim A. Eagle
Summary: Omega-3 polyunsaturated fatty acids play a key role in heart-healthy diet, and can be obtained through fatty fish consumption or fish oil supplementation. They not only treat hypertriglyceridemia, but also prevent cardiovascular events, with additional benefits such as reducing inflammation and improving plaque stability.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Chemistry, Medicinal
Lena Stiefvatter, Katja Lehnert, Konstantin Frick, Alexander Montoya-Arroyo, Jan Frank, Walter Vetter, Ulrike Schmid-Staiger, Stephan C. Bischoff
Summary: The microalgae Phaeodactylum tricornutum (PT) is a valuable source of nutrients such as proteins, polyunsaturated omega-3 fatty acids (n-3 PUFA), particularly eicosapentaenoic acid (EPA), carotenoids like fucoxanthin (FX), and beta-glucans. Intake of PT leads to an increase in n-3 PUFA and EPA levels, while also decreasing the n-6:n-3 ratio in plasma. The study shows that PT is a safe and effective source of EPA and other nutrients, suggesting its potential as a sustainable food source.
Review
Peripheral Vascular Disease
Samuel C. R. Sherratt, Peter Libby, Matthew J. Budoff, Deepak L. Bhatt, R. Preston Mason
Summary: This review examines the effects of omega-3 fatty acids (n3-FAs) on cardiovascular risk reduction. It has been found that high-purity EPA ethyl ester has significant benefits in reducing cardiovascular events and atherosclerosis progression compared to mixed EPA/DHA treatments. Mechanistic differences between n3-FAs, including membrane interactions, metabolic products, cholesterol efflux, antioxidant properties, and tissue distribution, have been explored.
CURRENT ATHEROSCLEROSIS REPORTS
(2023)
Article
Cardiac & Cardiovascular Systems
Subodh Verma, Deepak L. Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Nitish K. Dhingra, Steven B. Ketchum, Rebecca A. Juliano, Lixia Jiao, Ralph T. Doyle, Craig Granowitz, C. Michael Gibson, Duane Pinto, Robert P. Giugliano, Matthew J. Budoff, R. Preston Mason, Jean-Claude Tardif, Christie M. Ballantyne
Summary: In patients with a history of coronary artery bypass grafting, treatment with icosapent ethyl in the REDUCE-IT trial led to significant reductions in both first and recurrent ischemic events compared to placebo, with similar safety findings between groups.
Article
Nutrition & Dietetics
Maria Dolores Mesa, Fernando Gil, Pablo Olmedo, Angel Gil
Summary: This study aims to estimate the amount of n-3 LC-PUFA provided by commonly consumed fishes, shrimps, and mollusks, to conduct a risk-benefit analysis of fish consumption. Consuming 2-3 servings of a variety of fishery products per week can help meet recommended n-3 LC-PUFA levels while maintaining a balance to avoid potential risks from contaminants.
Article
Biochemistry & Molecular Biology
Ines Drenjancevic, Jan Pitha
Summary: In addition to proven medications, omega-3 polyunsaturated fatty acids (n-3 PUFAs) are considered to have additive effects on cardiovascular health. They influence the cardiovascular system through various mechanisms, including effects on metabolism, inflammation, thrombosis, and direct effects on cells.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Medicine, General & Internal
Marijana Tadic, Carla Sala, Guido Grassi, Giuseppe Mancia, Stefano Taddei, Wolfgang Rottbauer, Cesare Cuspidi
Summary: Omega-3 fatty acids show promise in reducing cardiovascular risk in patients with high triglycerides, especially in secondary prevention. Apart from triglyceride reduction, omega-3 fatty acids may have other cardiovascular benefits that warrant further investigation.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Sport Sciences
Jon-Kyle Davis, Eric C. Freese, Anthony S. Wolfe, Steven A. Basham, Kimberly M. W. Stein
Summary: The study evaluated the omega-3 PUFA blood concentrations, dietary, and supplement intake of 119 professional basketball players, with many players having insufficient fish consumption per week and only a few players supplementing with omega-3 PUFA.
JOURNAL OF STRENGTH AND CONDITIONING RESEARCH
(2021)
Article
Cardiac & Cardiovascular Systems
Arjun Majithia, Deepak L. Bhatt, Allon N. Friedman, Michael Miller, Ph Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixia Jiao, Ralph T. Doyle, Craig Granowitz, Matthew Budoff, R. Preston Mason, Jean-Claude Tardif, William E. Boden, Christie M. Ballantyne
Summary: In the REDUCE-IT trial, icosapent ethyl reduced fatal and nonfatal ischemic events across a broad range of baseline eGFR categories.
Article
Biochemistry & Molecular Biology
Juan Li, Meiru Mao, Jiacheng Li, Ziteng Chen, Ying Ji, Jianglong Kong, Zhijie Wang, Jiaxin Zhang, Yujiao Wang, Wei Liang, Haojun Liang, Linwen Lv, Qiuyang Liu, Ruyu Yan, Hui Yuan, Kui Chen, Yanan Chang, Guogang Chen, Gengmei Xing
Summary: This study assessed the effects of omega-3 fatty acids on alleviating inflammation and lung injury induced by PM2.5 inhalation exposure. It was found that oral administration of DHA and EPA effectively restored normal inflammatory cytokine levels and reduced lung parenchymal lesions in mice exposed to PM2.5.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Biotechnology & Applied Microbiology
Wenjia Gu, John M. M. Kavanagh, Dale D. D. McClure
Summary: There is an increasing demand for sustainable sources of omega-3 fatty acids, and microalgae can be used to produce eicosapentaenoic acid (EPA) on a large scale. The choice of suitable strains is crucial for successful production. However, findings from small-scale systems do not always translate to larger photobioreactors. In this study, the productivity and fatty acid composition of eleven microalgal strains were examined in both flask and photobioreactor cultures. The results showed that predictions based on flask screening were not accurate for photobioreactors, highlighting the need for improved screening tools. Among the species tested, Phaeodactylum tricornutum showed the most potential when grown in photobioreactors. The study also investigated the impact of environmental conditions (temperature and salinity) on EPA production and found that EPA content remained relatively constant within the tested temperature and salinity ranges. Finally, nutritional information about the biomass was provided, which can be used as a starting point for formulating food products.
ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS
(2022)
Article
Nutrition & Dietetics
Martin E. Reiner, Philipp Baumgartner, Andrea Wiencierz, Michael Coslovsky, Nicole R. Bonetti, Mark G. Filipovic, Giulia Montrasio, Stefanie Aeschbacher, Nicolas Rodondi, Oliver Baretella, Michael Kuehne, Giorgio Moschovitis, Pascal Meyre, Leo H. Bonati, Thomas F. Luescher, Giovanni G. Camici, Stefan Osswald, David Conen, Juerg H. Beer
Summary: The study showed that EPA and DPA were associated with large noncortical or cortical infarcts (LNCCIs) in patients with atrial fibrillation, with EPA negatively correlated and DPA positively correlated with LNCCIs. However, there was no significant correlation between EPA and DPA with markers of small vessel disease in atrial fibrillation patients.
Article
Cardiac & Cardiovascular Systems
Robert S. Rosenson, Aleesha Shaik, Wenliang Song
Summary: Elevated concentrations of triglyceride-rich lipoprotein remnants (TRLs) are linked to atherosclerotic cardiovascular events, with new therapies targeting TRL metabolism pathways showing promise in reducing atherosclerosis. Clinical trials of these therapies, such as inhibitors of angiopoietin-like 3 protein and apolipoprotein C-III, will provide further guidance on cardiovascular risk management in patients with elevated remnant cholesterol.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Michael R. R. Duggan, Lauren Butler, Zhongsheng Peng, Gulzar N. N. Daya, Abhay Moghekar, Yang An, Stephen R. R. Rapp, Kathleen M. M. Hayden, Aladdin H. H. Shadyab, Ginny Natale, Longjian Liu, Linda Snetselaar, Ruin Moaddel, Casey M. M. Rebholz, Kevin Sullivan, Christie M. M. Ballantyne, Susan M. M. Resnick, Luigi Ferrucci, Keenan A. A. Walker
Summary: Dysregulation of the immune system and inflammatory dietary patterns may increase the risk for cognitive decline. Proteomic assays of plasma samples identified a group of proteins linked to future cognitive impairment, as well as associations with dementia risk and biomarkers of Alzheimer's disease and neurodegeneration.
MOLECULAR PSYCHIATRY
(2023)
Review
Nutrition & Dietetics
Lisa M. Sanders, Mary R. Dicklin, Yong Zhu, Kevin C. Maki
Summary: Observational studies suggest that children and adolescents who consume ready-to-eat cereals (RTECs) have a healthier BMI and lower risk of overweight/obesity compared to those who consume other breakfasts or skip breakfast. However, randomized controlled trials are limited and inconsistent in showing a causal relationship between RTEC intake and body weight or composition. This study aimed to evaluate the effects of RTEC intake on body weight and composition in children and adolescents. The qualitative analysis of relevant studies showed that RTEC consumers generally had lower BMI, lower prevalence of overweight/obesity, and more favorable indicators of abdominal obesity. Controlled trials were scarce but one study reported a modest weight loss in overweight/obese children with RTEC consumption and nutrition education. The majority of studies had low risk of bias, but a few had some concerns or high risk. In conclusion, while controlled trials do not directly show an effect of RTEC consumption on body weight or composition, the abundance of observational data supports the inclusion of RTECs as part of a healthy dietary pattern for children and adolescents.
ADVANCES IN NUTRITION
(2023)
Letter
Cardiac & Cardiovascular Systems
Salim S. S. Virani, David J. J. Ramsey, Dax Westerman, Mark K. K. Kuebeler, Liang Chen, Julia M. M. Akeroyd, Glenn T. T. Gobbel, Christie M. M. Ballantyne, Laura A. A. Petersen, Alexander Turchin, Michael E. E. Matheny
Letter
Cardiac & Cardiovascular Systems
Yiyi Zhang, Jacqueline S. Dron, Brandon K. Bellows, Amit V. Khera, Junxiu Liu, Pallavi P. Balte, Elizabeth C. Oelsner, Sami Samir Amr, Matthew S. Lebo, Anna Nagy, Gina M. Peloso, Pradeep Natarajan, Jerome I. Rotter, Cristen Willer, Eric Boerwinkle, Christie M. Ballantyne, Pamela L. Lutsey, Myriam Fornage, Donald M. Lloyd-Jones, Lifang Hou, Bruce M. Psaty, Joshua C. Bis, James S. Floyd, Ramachandran S. Vasan, Nancy L. Heard-Costa, April P. Carson, Michael E. Hall, Stephen S. Rich, Xiuqing Guo, Dhruv S. Kazi, Sarah D. de Ferranti, Andrew E. Moran
Article
Cardiac & Cardiovascular Systems
Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Bjoerkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa Gonzalez, Mark Hazebroek, Jennifer Ho, Anne-Cecile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad
Summary: This study identified protein biomarkers associated with new-onset heart failure in three independent cohorts. The inclusion of these biomarkers in addition to clinical risk factors improved the prediction of heart failure risk. The B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide were found to be particularly relevant in predicting heart failure.
CIRCULATION-HEART FAILURE
(2023)
Article
Endocrinology & Metabolism
Suzanne V. Arnold, James A. de Lemos, Luke Zheng, Robert S. Rosenson, Christie M. Ballantyne, Shushama Alam, Deepak L. Bhatt, Christopher P. Cannon, Mikhail Kosiborod, GOULD Investigators
Summary: The study aimed to examine the improvement in the use of optimal medical therapy (OMT) for patients with atherosclerotic cardiovascular disease (ASCVD) and diabetes. The study found that the use of secondary prevention in US patients with ASCVD and diabetes was suboptimal, with minimal improvement over time.
DIABETES OBESITY & METABOLISM
(2023)
Article
Pharmacology & Pharmacy
Paul M. Ridker, Lei Lei, Kausik K. Ray, Christie M. Ballantyne, Gary Bradwin, Nader Rifai
Summary: Bempedoic acid (BA) reduces hsCRP and LDL-C levels in patients with atherosclerotic disease and/or familial hypercholesterolemia. It also shows potential anti-inflammatory effects and has similar lipid-lowering and inflammation-inhibiting properties to statin therapy.
JOURNAL OF CLINICAL LIPIDOLOGY
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Christie M. Ballantyne, Mini Grace Varughese, Layla A. Abushamat
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Review
Nutrition & Dietetics
Lisa M. Sanders, Mary R. Dicklin, Yong Zhu, Kevin C. Maki
Summary: Results from observational studies show that consuming ready-to-eat cereal (RTEC) is linked to better diet quality, lower overweight/obesity rates, and less weight gain in adults compared to other breakfast options or skipping breakfast. However, randomized controlled trials (RCTs) have provided inconsistent results regarding the effects of RTEC consumption on body weight. This review includes 28 relevant studies (14 observational studies and 14 RCTs) and suggests that frequent RTEC consumers have lower BMI, lower prevalence of overweight/obesity, and less abdominal adiposity. The RCTs indicate that RTEC can be used as a meal or snack replacement in a hypocaloric diet, but it is not superior to other options for achieving weight loss.
ADVANCES IN NUTRITION
(2023)
Article
Cardiac & Cardiovascular Systems
Lena Mathews, Xiao Hu, Ning Ding, Junichi Ishigami, Mahmoud Al Rifai, Ron C. C. Hoogeveen, Josef Coresh, Christie M. M. Ballantyne, Elizabeth Selvin, Kunihiro Matsushita
Summary: A study on 9205 participants from the ARIC study found that higher levels of GDF15 protein were associated with bleeding events and improved the prediction of bleeding risk in individuals without cardiovascular disease.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Cardiac & Cardiovascular Systems
Marina Cuchel, Paul C. Lee, Lisa C. Hudgins, P. Barton Duell, Zahid Ahmad, Seth J. Baum, MacRae F. Linton, Sarah D. de Ferranti, Christie M. Ballantyne, John A. Larry, Linda C. Hemphill, Iris Kindt, Samuel S. Gidding, Seth S. Martin, Patrick M. Moriarty, Paul P. Thompson, James A. Underberg, John R. Guyton, Rolf L. Andersen, David J. Whellan, Irwin Benuck, John P. Kane, Kelly Myers, William Howard, David Staszak, Allison Jamison, Mary C. Card, Mafalda Bourbon, Joana R. Chora, Daniel J. Rader, Joshua W. Knowles, Katherine Wilemon, Mary P. McGowan
Summary: This study investigated the diagnosis and treatment of HoFH in the United States and found a low diagnosis rate and low treatment rate, highlighting the need for enhanced screening and treatment to reduce the burden of the disease.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Cardiac & Cardiovascular Systems
Brian Olshansky, Deepak L. L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. A. Brinton, Terry A. A. Jacobson, Steven B. B. Ketchum, Ralph T. T. Doyle Jr, Rebecca A. A. Juliano, Lixia Jiao, Peter R. R. Kowey, James A. A. Reiffel, Jean-Claude Tardif, Christie M. M. Ballantyne, Mina K. K. Chung
Summary: In the REDUCE-IT study, icosapent ethyl (IPE) reduced cardiovascular events but was associated with increased atrial fibrillation/atrial flutter (AF) hospitalization. The study analyzed the relationships between IPE and outcomes in patients with or without prior AF and with or without in-study AF hospitalization. Overall, in-study AF hospitalization rates were higher in patients with prior AF, especially in those randomized to IPE. Serious bleeding rates also trended higher in these patients. However, patients with prior AF or in-study AF hospitalization showed consistent risk reductions in cardiovascular events with IPE.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)
Article
Cardiac & Cardiovascular Systems
Xiaoming Jia, Mahmoud Al Rifai, Ron Hoogeveen, Justin B. Echouffo-Tcheugui, Amil M. M. Shah, Chiadi E. Ndumele, Salim S. Virani, Biykem Bozkurt, Elizabeth Selvin, Christie M. Ballantyne, Vijay Nambi
Summary: This study assessed the association between change in NT-proBNP and the risk for incident heart failure and death. The results showed that change in NT-proBNP was positively correlated with the risk of heart failure and death. Additionally, changes in blood pressure, cholesterol, triglyceride levels, body mass index, and estimated glomerular filtration rate were associated with change in NT-proBNP.
Review
Endocrinology & Metabolism
Kevin C. Maki, Carol F. Kirkpatrick, David B. Allison, Kishore M. Gadde
Summary: Obesity in the U.S. is associated with increased risk of major adverse cardiovascular events (MACE). Lifestyle interventions and older antiobesity drugs have limited effectiveness in reducing MACE risk, while bariatric surgery shows substantial weight reduction and lower subsequent MACE risk. Newer antiobesity drugs, such as semaglutide and tirzepatide, have shown promising efficacy for weight reduction and are being evaluated for their impact on MACE risk in cardiovascular outcomes trials.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM
(2023)
Article
Cardiac & Cardiovascular Systems
Austin Deets, Parag H. Joshi, Alvin Chandra, Kavisha Singh, Amit Khera, Salim S. Virani, Christie M. Ballantyne, James D. Otvos, Robin P. F. Dullaart, Eke G. Gruppen, Margery A. Connelly, Colby Ayers, Ann Marie Navar, Ambarish Pandey, John T. Wilkins, Anand Rohatgi
Summary: This study aimed to assess the association between levels of specific size-based HDL subspecies and atherosclerotic cardiovascular disease, and investigate their role in risk prediction.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2023)